Reverse Total Shoulder Arthroplasty
Conditions
Brief summary
To collect medium to long-term survivorship implant outcomes on the DePuy Delta Xtend Reverse Shoulder Stystem.
Interventions
DEVICEDePuy Delta Xtend Reverse TSA
Sponsors
Rothman Institute Orthopaedics
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
Patients whom were implanted with the DePuy Delta Xtend Reverse Total Shoulder System in the time frame indicated. Patients must be willing to sign the consent form and complete all follow-up visits.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Implant Survivorship | 10 years post-operative |
Countries
United States
Outcome results
None listed